.png){kind=icon}
Return
Complementing CD20 antibodies' effector functions
.png){kind=icon}
PRE
AI
DOI：10.1182/blood.2024027767.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
In this issue of Blood, Baskar et al describe an innovative approach to enhance CD20 antibody efficacy by employing their complement-activating capacity to deposit C3d as neoantigen for novel antibodies in xenografted mouse models.1
Journal
IF:
23.1
Papers:
5.6K
Citations:
16.6W
Organization
Cited Papers
ShareSaveUnlocking the Power of Complement-Dependent Cytotoxicity: Engineering Strategies for the Development of Potent Therapeutic Antibodies for Cancer Treatments.png)
BIODRUGS
BIODRUGSIF6.9
PREAI
ShareSaveDaratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS studyBlood
OAAI
BloodIF0
OAAIShareSaveAn anti-C3b(i) mAb enhances complement activation, C3b(i) deposition, and killing of CD20+ cells by rituximabBlood
OAAI
BloodIF0
OAAIShareSave no more
no more